C. J. Corrigan (London, UK), P. Chanez (Montpellier, France)
Stable chronic obstructive pulmonary disease-bronchial colonization and inflammatory response
G. Stevcevska, G. Breskovska, J. Stojkovic, N. Pesic (Skopje, Macedonia)
|  |
Proinflammatory cytokines production in patients with purulent destructive lung diseases
A. Kotov, A. Salamatov, A. Simbirtsev (Saint-Petersburg, Russia)
| |
Immunodiagnosis of ABPA by use of ELISA and Immuno CAP - system
G. Willer, R. Crameri, G. Menz (Davos, Switzerland)
| |
IL-8 and heparan sulphate expression are increased in CF compared to normal airway tissue
J. W. Wilson, T. Kotsimbos, N. Solic, S. Wilson, J. Shute (Prahran, Australia; Southampton, United Kingdom)
| |
The role of IgA in recurrent respiratory infections (RRIs) in children
V. Gregorutti, M. Canciani, F. De Franco, M. Don, F. Braida (Udine, Italy)
| |
Selective IgA deficiency; a spectrum of presentations; a review of two cases with diverse presentations
L. Atarod, A. Farhoudi, Z. Pourpak (Tehran, Iran)
| |
Antibody deficiency in adults with recurrent respiratory tract infections
A. R. Exley, D. Bilton, A. Condliffe, S. Buckenham, J. Jones, J. Edmunds, K. Henderson (Cambridge, United Kingdom)
| |
Influence on cytokines of the immunocompromised hosts by inhaling IFN-γ via aerosol
Z. Ma, G. S. Qian, G. J. Huang (Shenyang, China)
| |
Effects of essential phospholipids on biochemical and immunological indices at sarcoidosis of respiratory organs
G. L. Borodina, N. S. Shpakovskaya, V. S. Kamyshnikov (Minsk, Belarus)
| |
Th1/Th2 and Tc1/Tc2 profiles in bronchoalveolar lavage and sputum induction in pulmonary sarcoidosis
I. Tsiligianni, D. Kyriakou, N. Tzanakis, G. Chrysophakis, N. Siafakas, D. Bouros (Heraklion, Greece)
| |
Increased IL-16 production in sarcoidosis
A. Prasse, C. Hofmann, H. Matthys, W. Luttmann, J. C. Virchow Jr (Freiburg, Germany)
| |
Prognostic value of HLA typing in Irish patients with pulmonary sarcoidosis
R. M. Rutherford, M. Kearns, M. Burke, F. Stevens, J. J. GiImartin (Galway, Ireland)
| |
Incidence of coeliac disease in patients with sarcoidosis
R. M. Rutherford, T. Azher, F. Stevens, M. Kearns, J. J. Gilmartin (Galway, Ireland)
| |
Cytokine regulation in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis: clinicomorphological study
V. V. Denguine, E. A. Kogan, B. M. Kornev, G. Jaques (Moscow, Russia; Marburg, Germany)
| |
The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis
A. Kalinina, T. Ses, L. Novikova, M. Malyshev, A. Bazhanov, E. Leontieva (St.Petersburg, Russia)
| |
Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF)
L. A. Kolodkina, T. P. Ses, G. P. Orlova, L. N. Novikova, A. S. Kalinina (Saint-Petersburg, Russia)
| |
Allergic respiratory diseases and rheumatoid arthritis
G. Provenzano, F. Rinaldi, G. Brai, G. Donato (Palermo, Italy)
| |
Chosen lymphocytic subpopulations in the course of interstitial lung diseases
R. M. Mroz, E. Chyczewska, A. Holownia, J. J. Braszko (Bialystok, Poland)
| |
Lipopolysaccharide (LPS) inhalation causes an increase in activated neutrophils and lymphocytes
M. I. Allenby, M. W. Lethbridge, R. I. Ketchell, F. W. Woisin, M. Jensen, D. M. Kemeny, B. J. O'Connor (London, United Kingdom)
| |
IFN γ and IL2 secretion in whole blood culture after simulation with mitogens in patients with tuberculosis- comparison with healthy donors
J. Śledziewska, J. Szopinski, E. Roginska, E. Rogala, E. Rowinska- Zakrzewska (Warsaw, Poland)
| |